Pravastatin sodium and Primary sequestrum - a phase IV clinical study of FDA data

Summary:

Primary sequestrum is reported as a side effect among people who take Pravastatin sodium (pravastatin sodium), especially for people who are female, 60+ old, also take Zometa, and have Calcium deficiency.

The phase IV clinical study analyzes which people have Primary sequestrum when taking Pravastatin sodium. It is created by eHealthMe based on reports of 23,888 people who have side effects when taking Pravastatin sodium from the FDA, and is updated regularly.

What is Pravastatin sodium?

Pravastatin sodium has active ingredients of pravastatin sodium. It is often used in high blood cholesterol. eHealthMe is studying from 26,520 Pravastatin sodium users. Check the latest studies of Pravastatin sodium.

What is Primary sequestrum?

Primary sequestrum (piece of dead bone that has become separated during the process of necrosis from normal/sound bone) is found to be associated with 598 drugs and 330 conditions by eHealthMe. Check the latest studies of Primary sequestrum.

On Jul, 18, 2026

23,888 people reported to have side effects when taking Pravastatin sodium.
Among them, 19 people (0.08%) have Primary sequestrum.

Could Pravastatin sodium cause Primary sequestrum?

Among these 19 people:

What is the gender of people who have Primary sequestrum when taking Pravastatin sodium? *

female: 100 %
male: 0.0 %

What is the age of people who have Primary sequestrum when taking Pravastatin sodium? *

What are other drugs people take besides Pravastatin sodium? *

What are other side effects people have besides Primary sequestrum? *

Pain: 17 people, 89.47%
Swelling: 17 people, 89.47%
Osteonecrosis Of Jaw (death of bone of jaw): 16 people, 84.21%
Tooth Loss: 15 people, 78.95%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 15 people, 78.95%
Dental Fistula: 15 people, 78.95%
Purulent Discharge (discharge that contains pus): 15 people, 78.95%
Haemorrhoids (a swollen vein or group of veins in the region of the anus): 14 people, 73.68%
Emotional Distress: 14 people, 73.68%
Fainting (loss of consciousness and postural tone): 14 people, 73.68%

What are the existing conditions these people have? *

Neoplasm Malignant (cancer tumour): 14 people, 73.68%
Metastases To Spine (cancer spreads to spine): 14 people, 73.68%
Calcium Deficiency (lack of calcium): 14 people, 73.68%
Lung Neoplasm (tumour of lung): 13 people, 68.42%
Metastases To Bone (cancer spreads to bone): 5 people, 26.32%
Osteoporosis (bones weak and more likely to break): 2 people, 10.53%
Breast Cancer: 2 people, 10.53%
Trigeminal Neuralgia (a painful condition of the nerve responsible for most facial sensation): 1 person, 5.26%
Pulmonary Mass: 1 person, 5.26%
Peripheral Arterial Occlusive Disease (reproducible ischemic muscle pain): 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Pravastatin sodium and have Primary sequestrum?

- Check whether Primary sequestrum is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pravastatin sodium:

Pravastatin sodium (26,520 reports)

Browse all side effects of Pravastatin sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Primary sequestrum:

Primary sequestrum (598 drugs)

Browse all the conditions that are associated with Primary sequestrum:

Primary sequestrum (330 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pravastatin sodium (the active ingredients of Pravastatin sodium) and Pravastatin sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.